$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Pharmaceutical formulations of osteogenic proteins 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07K-014/51
출원번호 US-0081378 (1993-06-29)
국제출원번호 PCT/US92/05309 (1992-06-22)
§371/§102 date 19930629 (19930629)
국제공개번호 WO-9300050 (1993-01-07)
발명자 / 주소
  • Ron Eyal (Lexington MA) Turek Thomas J. (Boston MA) Isaacs Benjamin S. (Tewksbury MA) Patel Himakshi (Tewksbury MA) Kenley Richard A. (Andover MA)
출원인 / 주소
  • Genetics Institute, Inc. (Cambridge MA 02)
인용정보 피인용 횟수 : 124  인용 특허 : 12

초록

A composition comprising a pharmaceutically acceptable admixture of an osteogenic protein; a polymer matrix component selected from the group consisting of poly(lactic acid), poly(glycolic acid), and copolymers of lactic acid and glycolic acid; and an osteogenic protein-sequestering material.

대표청구항

A composition comprising a pharmaceutically acceptable admixture of (i) an ostcogenic protein; (ii) a polymer matrix component selected from the group consisting of poly(lactic acid), poly(glycolic acid), and copolymers of lactic acid and glycolic acid; and (iii) an osteogenic protein-sequestering a

이 특허에 인용된 특허 (12)

  1. Urist Marshall R. (Pacific Palisades CA), Biodegradable organic polymer delivery system for bone morphogenetic protein.
  2. Kuberasampath Thangavel (Medway MA) Ridge Richard J. (Acton MA), Bone collagen matrix for zenogenic implants.
  3. Schmitt Edward Emil (Palo Alto CA) Polistina Rocco Albert (Port Chester NY), Controlled release of medicaments using polymers from glycolic acid.
  4. Yamamoto Masaki (Osaka JPX) Takada Shigeyuki (Suita JPX) Ogawa Yasuaki (Ibaraki ; all JPX), Method for producing microcapsule.
  5. Kuberasampath Thangavel (Medway MA) Rueger David C. (West Roxbury MA), Osteogenic devices.
  6. Wang Elizabeth A. (Carlisle MA) Wozney John M. (Hudson MA) Rosen Vicki (Boston MA), Osteoinductive factors.
  7. Higashi Kiyotsugu (Nara JPX) Kametaka Shigeru (Osaka JPX) Izumi Reiko (Osaka JPX) Morisaki Katsuhiko (Nara JPX) Hayashi Shin\ichi (Osaka JPX), Pharmaceutical composition for treating periodontal.
  8. Schmitz John P. (Columbia MD), Polyactic-polyglycolic acid copolymer combined with decalcified freeze-dried bone for use as a bone repair material.
  9. Nieuwenhuis Jan (Gorinchem NLX) Mol Arie C. (Papendrecht NLX), Polymer lactide, method for preparing it and a composition containing it.
  10. Augurt Thomas Anthony (Stamford CT) Rosensaft Michael Norman (Monsey NY) Perciaccante Vincent Anthony (Long Island NY), Polymers of unsymmetrically substituted 1,4-dioxane-2,5-diones.
  11. DeLuca Patrick P. (Lexington KY) Kanke Motoko (Fukuyama JPX) Sato Toyomi (Tokyo CA JPX) Schroeder Hans G. (Encinitas CA), Porous microspheres for drug delivery and methods for making same.
  12. Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Yashiki Takatsuka (Hyogo JPX), Prolonged release microcapsules.

이 특허를 인용한 특허 (124)

  1. Bachert, Alice; Mercuri, Jeremy, Bioactive flowable wash-out resistant bone graft material and method for production thereof.
  2. Izoret Georges,FRX, Bioadhesive; preparation procedure and device for the application of a bioadhesive; and hardeners for a bioadhesive.
  3. Edelman, Jeffrey L.; Hughes, Patrick M.; Malone, Thomas C.; De Vries, Gerald W.; Chang-Lin, Joan-En; Shiah, Jane Guo; Nivaggioli, Thierry; Spada, Lon T.; Blanda, Wendy M., Biodegradable intravitreal tyrosine kinase implants.
  4. Edelman, Jeffrey L.; Hughes, Patrick M.; Malone, Thomas C.; DeVries, Gerald W.; Chang-Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry; Spada, Lon T.; Blanda, Wendy M., Biodegradable intravitreal tyrosine kinase implants.
  5. Edelman, Jeffrey L.; Hughes, Patrick M.; Malone, Thomas C.; DeVries, Gerald W.; Chang-Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry; Spada, Lon T.; Blanda, Wendy M., Biodegradable intravitreal tyrosine kinase implants.
  6. Comfort Christopher J., Bone augmentation for prosthetic implants and the like.
  7. Comfort Christopher J., Bone augmentation for prosthetic implants and the like.
  8. Hair, Gregory A.; Boden, Scott D., Bone mineralization proteins, DNA, vectors expression systems.
  9. Gregory A. Hair ; Scott D. Boden, Bone mineralization proteins, DNA, vectors, expression systems.
  10. Hair Gregory A. ; Boden Scott D., Bone mineralization proteins, DNA, vectors, expression systems.
  11. Hair, Gregory A.; Boden, Scott D., Bone mineralization proteins, DNA, vectors, expression systems.
  12. Chang, James N.; Hughes, Patrick M.; Devries, Gerald W., Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems.
  13. Seyedin, Mitchell S.; Matava, Matthew, Cartilage repair methods.
  14. Hughes, Patrick M.; Olejnik, Orest; Whitcup, Scott M.; Burke, James A., Compositions and methods for localized therapy of the eye.
  15. Trogden, John T.; Salameh, Adnan K.; Pujara, Chetan P., Compositions and methods for stimulating hair growth.
  16. Shirley, Bret A.; Bajwa, Kamaljit, Compositions providing for increased IGF-I solubility.
  17. Shirley, Bret A.; Bajwa, Kamaljit, Compositions providing for increased IGF-I solubility.
  18. Shirley,Bret A.; Bajwa,Kamaljit, Compositions providing for increased IGF-I solubility.
  19. Seyedin, Mitchell S.; Ward, Anthony J., Flexible tissue matrix and methods for joint repair.
  20. Seyedin, Mitchell S.; Ward, Anthony J.; Matava, Matthew, Flexible tissue matrix and methods for joint repair.
  21. Wong,Vernon; Kochinke,Frank, Formulation for controlled release of drugs by combining hyrophilic and hydrophobic agents.
  22. Aeschlimann, Daniel; Bulpitt, Paul, Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same.
  23. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related implants.
  24. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  25. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  26. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  27. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  28. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  29. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  30. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  31. Hughes, Patrick M., Hypotensive prostamide-containing biodegradable intraocular implants and related methods.
  32. Beyer, Jr., Wayne F.; Hyde-DeRuyscher, Robin; Hamilton, Paul T.; Benson, Ray Edward, IFBM's to promote the specific attachment of target analytes to the surface of orthopedic implants.
  33. Beyer, Jr., Wayne F.; Hyde-DeRuyscher, Robin; Hamilton, Paul T.; Benson, Ray Edward, IFBM's to promote the specific attachment of target analytes to the surface of orthopedic implants.
  34. Beyer, Jr., Wayne F.; Hyde-DeRuyscher, Robin; Hamilton, Paul T.; Benson, Ray Edward, IFBM's to promote the specific attachment of target analytes to the surface of orthopedic implants.
  35. Asius, Jerome; Fessi, Hatem; Gouchet, Franck; Laglenne, Benedicte; Laugier-Laglenne, Elisabeth, Implant for subcutaneous or intradermal injection.
  36. Asius, Jérôme; Fessi, Hatem; Gouchet, Franck; Laglenne, Bénedicte; Laugier-Laglenne, Elisabeth, Implant for subcutaneous or intradermal injection.
  37. Nies Berthold,DEX, Implant material having an excipient/active compound combination.
  38. Wong, Vernon G.; Hu, Mae W. L., Implants and methods for treating inflammation-mediated conditions of the eye.
  39. Wong, Vernon G.; Hu, Mae W. L., Implants and methods for treating inflammation-mediated conditions of the eye.
  40. Wong, Vernon G.; Hu, Mae W. L., Implants and methods for treating inflammation-mediated conditions of the eye.
  41. Wong, Vernon G.; Hu, Mae W. L., Implants and methods for treating inflammation-mediated conditions of the eye.
  42. Hughes, Patrick M.; Sarrazin, Christian; Rossi, Elisabeth; Boix, Michele, Intraocular biodegradable microspheres.
  43. Robinson, Michael R.; Blanda, Wendy M.; Hughes, Patrick M.; Ruiz, Guadalupe; Orilla, Werhner C.; Whitcup, Scott M.; Welty, Devin F.; Lin, Joan-En; Spada, Lon T., Intraocular drug delivery systems.
  44. Hughes, Patrick M., Intraocular pressure reduction with intracameral bimatoprost implants.
  45. Spada, Lon T.; Shiah, Jane Guo; Hughes, Patrick; Malone, Thomas C.; Devries, Gerald W.; Edelman, Jeffrey L.; Wurster, Julie A.; Guo, Xialing; Boral, Sougato, Kinase inhibitors.
  46. Seyedin, Mitchell S.; Spiro, Robert, Matrix made of polyester polymers entangled with hyaluronic polymers useful for supporting tissue repair.
  47. Gayer Gregory G. ; Comfort Christopher J., Method and apparatus for augmentating osteointegration of prosthetic implant devices.
  48. Gregory G. Gayer ; Christopher J. Comfort, Method and apparatus for augmenting osteointegration of prosthetic implant devices.
  49. Jennissen, Herbert; Chatzinikolaidou, Maria, Method for producing a product having a polymer matrix, implants made thereof and use thereof.
  50. Dalal, Paresh S.; Diamaano, Godofredo R.; Kulkarni, Shailesh C., Method for producing porous β-tricalcium phosphate granules.
  51. Wong, Vernon G, Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor.
  52. Wong, Vernon G., Method for reducing transplant rejection in the eye and intraocular implants for use therefor.
  53. Asius, Jerome; Fessi, Hatem; Gouchet, Franck; Laglenne, Benedicte; Laugher-Laglenne, Elisabeth, Method for subcutaneous or intradermal injection.
  54. Dalal,Paresh S; Dimaano,Godofredo R; Toth,Carol A; Kulkarni,Shailesh C, Method of delivering a bioactive agent with porous β-tricalcium phosphate granules.
  55. Dalal,Paresh S; Dimaano,Godofredo R; Toth,Carol A; Kulkarni,Shailesh C, Method of forming bone with porous βtricalcium phosphate granules.
  56. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Method of making oil-in-oil emulsified polymeric implants containing a hypotensive lipid.
  57. Hughes, Patrick M.; Sarrazin, Christian; Rossi, Elisabeth; Boix, Michèle, Method of making tyrosine kinase microspheres.
  58. Wong, Vernon G., Methods for reducing edema.
  59. Wong, Vernon G., Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use.
  60. Wong, Vernon G, Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor.
  61. Wong, Vernon G., Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor.
  62. Wong, Vernon G., Methods for treating edema in the eye and intraocular implants for use therefor.
  63. Wong, Vernon G., Methods for treating edema in the eye and intraocular implants for use therefor.
  64. Whitcup, Scott M.; Weber, David A., Methods for treating retinopathy with extended therapeutic effect.
  65. Whitcup, Scott M.; Weber, David A., Methods for treating retinopathy with extended therapeutic effect.
  66. Whitcup, Scott M.; Weber, David A., Methods for treating retinopathy with extended therapeutic effect.
  67. Seyedin, Mitchell S.; Gage, Gary, Methods of tissue repair and compositions therefor.
  68. Huang, Glenn T.; Nivaggioli, Thierry; Spada, Lon T.; Sugimoto, Hiroshi; Blanda, Wendy M.; Chang, James N.; Olejnik, Orest, Methods of treating ocular disease using steroid-containing sustained release intraocular implants.
  69. Chang, James; Hughes, Patrick; Chang, Chin-Ming, Microparticles manufactured in an oil-in-water process comprising a prostamide.
  70. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  71. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  72. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  73. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  74. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  75. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  76. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  77. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and prostamide.
  78. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods.
  79. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods.
  80. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods.
  81. Chang, James; Hughes, Patrick; Chang, Chin-Ming, Oil-in-water method for making polymeric implants containing a hypotensive lipid.
  82. Chang, James; Hughes, Patrick; Chang, Chin-Ming, Oil-in-water method for making polymeric implants containing a hypotensive lipid.
  83. Garigapati, Venkat R.; TenHuisen, Kevor S., Organophosphorous and multivalent metal compound compositions and methods.
  84. Garigapati, Venkat R.; Hess, Brian J.; Kimsey, Cassandra L.; Murphy, Matthew E., Organophosphorous, multivalent metal compounds, and polymer adhesive interpenetrating network compositions and methods.
  85. Rueger,David C.; Tucker,Marjorie M., Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects.
  86. Rueger,David C.; Tucker,Marjorie M., Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects.
  87. Rueger, David C.; Tucker, Marjorie M., Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects.
  88. Rueger, David C.; Tucker, Marjorie M.; Chang, An-Cheng, Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects.
  89. Rueger, David C.; Tucker, Marjorie M.; Chang, An-Cheng, Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects.
  90. McKay, William F.; Estes, Bradley T., Osteogenic packing device and method.
  91. McKay, William F.; Estes, Bradley T., Osteogenic packing device and method.
  92. Lyons, Robert T.; Robinson, Michael R.; Trogden, John T.; Whitcup, Scott M., Peripherally administered viscous formulations.
  93. Whitcup, Scott M.; Robinson, Michael R.; Lyons, Robert T.; Trogden, John T., Peripherally administered viscous formulations.
  94. Lyons, Robert T.; Chang, James N.; Trogden, John T.; Whitcup, Scott, Pharmaceutical compositions.
  95. Sebald,Walter, Polypeptide variants with increased heparin-binding capacity.
  96. Dalal, Paresh S.; Dimaano, Godofredo R.; Toth, Carol Ann; Kulkarni, Shailesh C., Porous β-tricalcium phosphate granules for regeneration of bone tissue.
  97. Somers,Fabian; Faict,Dirk, Stabilization of pharmaceutical protein formulations with small peptides.
  98. Kageyama, Yukako; Fujinaga, Kentaro; Yamaguchi, Ayuko; Honda, Susumu; Satake, Makoto; Kaneko, Hiroaki; Ishiwari, Ayumi, Sterile composition.
  99. Huang, Glenn T.; Nivaggioli, Thierry; Spada, Lon T.; Sugimoto, Hiroshi; Blanda, Wendy M.; Chang, James N.; Olejnik, Orest, Steroid-containing sustained release intraocular implants and related methods.
  100. Huang, Glenn T.; Nivaggioli, Thierry; Spada, Lon T.; Sugimoto, Hiroshi; Blanda, Wendy M; Chang, James N.; Olejnik, Orest, Steroid-containing sustained release intraocular implants and related methods.
  101. Robinson, Michael R.; Whitcup, Scott M., Steroid-containing sustained release intraocular implants and related methods.
  102. Shiah, Jane-Guo; Pujara, Chetan, Sustained drug delivery implant.
  103. Shiah, Jane-Guo; Pujara, Chetan, Sustained drug delivery implant.
  104. Burke, James; Hughes, Patrick M.; Werhner, Orilla C.; Lin, Ton C.; Escobar, Maria; Huang, Glenn; Zhang, Kai-Ming; Wheeler, Larry A.; Donn, Rosy S., Sustained release intraocular implants and methods for preventing retinal dysfunction.
  105. Huang, Glenn T.; Burke, James A.; Hughes, Patrick M.; Zhang, Kai-Ming; Lin, Ton; Wheeler, Larry A.; Sheng, Rosy, Sustained release intraocular implants and methods for preventing retinal dysfunction.
  106. Huang, Glenn T.; Burke, James; Hughes, Patrick M.; Zhang, Kai-Ming; Lin, Ton; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for preventing retinal dysfunction.
  107. Huang, Glenn T.; Burke, James; Hughes, Patrick M.; Zhang, Kai-Ming; Lin, Ton; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for preventing retinal dysfunction.
  108. Huang, Glenn T.; Nivaggioli, Thierry, Sustained release intraocular implants and methods for treating ocular neuropathies.
  109. Huang, Glenn T.; Jackson, Brittany; Burke, James A.; Lin, Ton; Hughes, Patrick M.; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for treating ocular vasculopathies.
  110. Huang, Glenn T.; Jackson, Brittany; Burke, James A.; Lin, Ton; Hughes, Patrick M.; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for treating ocular vasculopathies.
  111. Huang, Glenn T; Jackson, Brittany; Burke, James A.; Lin, Ton; Hughes, Patrick M.; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for treating ocular vasculopathies.
  112. Huang, Glenn T; Jackson, Brittany; Burke, James A.; Lin, Ton; Hughes, Patrick M.; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for treating ocular vasculopathies.
  113. Huang, Glenn T.; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  114. Huang, Glenn T.; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  115. Huang, Glenn T.; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  116. Huang, Glenn T; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  117. Huang, Glenn T; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  118. Hughes, Patrick M.; Malone, Thomas C.; De Vries, Gerald W.; Edelman, Jeffery L.; Chang-Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry, Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods.
  119. Hughes, Patrick M.; Malone, Thomas C.; De Vries, Gerald W.; Edelman, Jeffery L.; Chang-Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry, Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods.
  120. Hughes, Patrick M.; Malone, Thomas C.; De Vries, Gerald W.; Edelman, Jeffrey L.; Chang-Lin, Joan-En; Shiah, Jane Guo; Nivaggioli, Thierry, Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods.
  121. Hughes, Patrick M.; Malone, Thomas C.; DeVries, Gerald W.; Edelman, Jeffrey L.; Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry, Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods.
  122. Marjorie M. Tucker ; David C. Rueger ; Kuber T. Sampath, Terminally sterilized osteogenic devices and preparation thereof.
  123. Tucker Marjorie M. ; Rueger David C. ; Sampath Kuber T., Terminally sterilized osteogenic devices and preparation thereof.
  124. Tucker, Marjorie M.; Rueger, David C.; Sampath, Kuber T., Terminally sterilized osteogenic devices and preparation thereof.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로